Cargando…
Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
Metastatic prostate cancer (mPCa) is one of the most prevalent cancers in men worldwide. The main cause of death in these patients is androgen-resistant metastatic disease. Surgery of the primary tumor has been avoided in these patients as there is no strong evidence that supports a beneficial effec...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722890/ https://www.ncbi.nlm.nih.gov/pubmed/26503286 http://dx.doi.org/10.3892/or.2015.4319 |